News

Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement of KB295 to a Phase 2 Clinical Study in Mild-to-Moderate Ulcerative Colitis

KB295 reached its primary endpoint demonstrating favorable safety and tolerability profile Reduction in key ulcerative colitis biomarkers correlated with disease...

Vital Data Technology Launches Affinitē Insights™ for Near Real-Time Gap Closure to Speed Up Targeted Intervention and Support Value-Based Care Models

NEWPORT BEACH, Calif., Oct. 5, 2021 /PRNewswire/ -- Vital Data Technology, a data science-driven healthcare solutions leader, announces today the release...

error: Content is protected !!